MAPT and Alzheimer disease: This observation provides the foundation for further work aimed at linking those pathologies at the molecular level and identifying kinases or other proteins that connect neuroinflammation, Tau pathology, the induction of the necrosome, and components of the GVD in a consistent pathway that can be targeted for the treatment of AD.